The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
News|Articles|January 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of December 30, 2021, at 1:54 PM, EDT:
• 73.3% of total US population has received at least 1 dose
• 62% of total US population is fully vaccinated
• 62% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Vermont: 77.4%
2. Puerto Rico: 77%
3. Rhode Island:76.5%
4. Maine: 75.8%
5. Connecticut: 74.6%
2. Puerto Rico: 77%
3. Rhode Island:76.5%
4. Maine: 75.8%
5. Connecticut: 74.6%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, January 3, 2022 at 3:22 PM, EDT, there have been:
• 55 651 537 confirmed cases and
• 826 783 deaths
• 826 783 deaths
The 5 states with the highest total confirmed cases are:
1. California: 5 584 889
2. Texas: 4 592 774
3. Florida: 4 209 927
4. New York: 3 684 152
5. Illinois: 2 238 750
2. Texas: 4 592 774
3. Florida: 4 209 927
4. New York: 3 684 152
5. Illinois: 2 238 750
Deaths: California has the highest number of deaths due to COVID-19 with 76 534 reported fatalities, followed by Texas with 75 757 and Florida with 62 504.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 291 651 187 confirmed cases, 5 447 340 deaths, and 2 031 208 303 289 vaccine doses administered.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement